Practical Recommendations on Laboratory Monitoring in Patients with Atopic Dermatitis on Oral JAK Inhibitors

• Main Authors: Mark G. Kirchhof (Author), Vimal H. Prajapati (Author), Melinda Gooderham (Author), Chih-ho Hong (Author), Charles W. Lynde (Author), Catherine Maari (Author), Irina Turchin (Author), Kim A. Papp (Author)
• Format: Book
• Published: Adis, Springer Healthcare, 2024-08-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Oral Janus kinase inhibitors (JAKi), a class of advanced targeted systemic therapy, have demonstrated efficacy and safety in the treatment of moderate-to-severe atopic dermatitis (AD). Like other small molecules, oral JAKi have the potential for off-target effects including laboratory-relat...